Michael Khan adds voice to Silence board
This article was originally published in Scrip
Executive Summary
RNAi therapeutics company Silence Therapeutics has appointed Dr Michael Khan to its board of directors as chief medical advisor. Dr Khan is an associate professor of medicine at the UK's University of Warwick and a consultant physician at University Hospitals.